Cambridge Healthtech Institute

Latest speaker confirmed: John S. Yu, M.D., Professor & Vice Chairman, Neurosurgery, Cedars-Sinai Medical Center; Chairman & CSO, ImmunoCellular Therapeutics

CHI's Evidence-Based Reimbursement Summit well positioned to cover the recent CPT Code Changes enacted by the AMA. Features dedicated presentations on the effect these changes will have on Medicare, Medicaid, as well as private insurances policies.

Deploying Information Technology to Enable Innovation within the Future State of Care: Connecting Patients, Providers, and Payers

CHI’s Oncology Clinical Trials: Bringing Effective and Safe Cancer Therapy to Patient takes place Feb. 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2013.

Cambridge Healthtech Institute's inaugural Evidence-Based Reimbursement Summit is being held November 5-7, 2012 in Philadelphia, PA. Will feature Generating Evidence for Reimbursement Decisions: Therapeutics and Diagnostics.

The Fourth Annual Leaders in Biobanking Congress is only three weeks away! Don’t miss this record breaking event!

Aptiv Solutions, Berry Consultants and Tessella announce a one day forum to address the challenges in adopting adaptive trials in the drug, medical device and clinical research industry and assess the potential for transforming drug development.

Cambridge Healthtech Institute and Bio-IT World announce a call for speakers for the inaugural Medical Informatics World Conference.

Delegates now have the option to choose from 10 moderated breakout discussion groups at this industry leading event facilitated by FDA and industry and academic experts.

Cambridge Healthtech and Barnett International’s new dinner workshop, “Proactive Approaches to Vendor Management," will attract clinical research and trial management teams, medical officers and quality/regulatory professionals.